Skip to main content

Prototype Prescribing Outlier Dashboard for Helsby Health Centre

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Helsby Health Centre is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Epinastine hydrochloride 12 Other anti-inflammatory preparations 121 0.10 0.00 0.01 8.78
Cyclizine lactate 57 Drugs used in nausea and vertigo 647 0.09 0.01 0.02 4.55
Hydrogen peroxide 5 Oxidisers and dyes 5 1.00 0.06 0.22 4.30
Other oral iron preparations 18 Oral iron 740 0.02 0.00 0.01 3.60
Moxifloxacin hydrochloride 2 Ocular diagnostic & peri-operative prepn & photodynamic tt 5 0.40 0.03 0.11 3.55
Ethambutol hydrochloride 10 Antituberculosis drugs 15 0.67 0.06 0.18 3.41
Tiaprofenic acid 2 Non-steroidal anti-inflammatory drugs 1,026 0.00 0.00 0.00 2.99
Betaxolol 12 Treatment of glaucoma 835 0.01 0.00 0.00 2.97
Liquid paraffin 22 Emollient bath and shower preparations 97 0.23 0.03 0.07 2.76
Azelaic acid 38 Topical preparations for acne 169 0.22 0.07 0.06 2.75

Prescribing where Helsby Health Centre is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Potassium permanganate 0 Oxidisers and dyes 5 0.00 0.94 0.22 -4.23
    Midazolam hydrochloride 1 Drugs used in status epilepticus 9 0.11 0.80 0.28 -2.43
    Dexamethasone 7 Corticosteroids 74 0.09 0.49 0.22 -1.76
    Folic acid 826 Drugs used in megaloblastic anaemias 1,982 0.42 0.69 0.16 -1.76
    Methylprednisolone acetate 10 Local corticosteroid injections 65 0.15 0.74 0.39 -1.49
    Budesonide 3 Corticosteroids 13 0.23 0.71 0.32 -1.49
    Procyclidine hydrochloride 21 Antimuscarinic drugs used in parkinsonism 39 0.54 0.85 0.21 -1.49
    Hydroxychloroquine sulfate 77 Rheumatic disease suppressant drugs 547 0.14 0.37 0.16 -1.47
    Letrozole 32 Breast cancer 233 0.14 0.45 0.22 -1.43
    Topiramate 23 Control of epilepsy 2,508 0.01 0.04 0.02 -1.37